ID   JEM493
AC   CVCL_RP37
DR   cancercelllines; CVCL_RP37
DR   Wikidata; Q54898571
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:17087; ICOSLG; Simple; p.Glu153Ter (c.457G>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,19
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 12
ST   D8S1179: 11,14
ST   FGA: 19,24
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
RX   PubMed=29846633; DOI=10.1210/jc.2017-01845; PMCID=PMC6126888;
RA   Marlow L.A., Rohl S.D., Miller J.L., Knauf J.A., Fagin J.A., Ryder M.,
RA   Milosevic D., Netzel B.C., Grebe S.K.G., Reddi H.V., Smallridge R.C.,
RA   Copland J.A. 3rd;
RT   "Methodology, criteria, and characterization of patient-matched thyroid
RT   cell lines and patient-derived tumor xenografts.";
RL   J. Clin. Endocrinol. Metab. 103:3169-3182(2018).
//
RX   PubMed=30737244; DOI=10.1158/1078-0432.CCR-18-2953; PMCID=PMC6522280;
RA   Landa I., Pozdeyev N., Korch C.T., Marlow L.A., Smallridge R.C.,
RA   Copland J.A. 3rd, Henderson Y.C., Lai S.Y., Clayman G.L., Onoda N.,
RA   Tan A.-C., Garcia-Rendueles M.E.R., Knauf J.A., Haugen B.R.,
RA   Fagin J.A., Schweppe R.E.;
RT   "Comprehensive genetic characterization of human thyroid cancer cell
RT   lines: a validated panel for preclinical studies.";
RL   Clin. Cancer Res. 25:3141-3151(2019).
//